Contracting to counter gene patents – a 21st Century solution to access and innovation
By Sarah Ali-Khan and E. Richard Gold As Precision Medicine becomes a reality, molecular tests are an increasingly critical part of patient care. While patients and their physicians would like to maximize access, they have confronted a roadblock in the form of patents covering genes and methods of diagnosis. Many hoped that the landmark 2013…